Triple-Negative Breast Cancer (TNBC) Withdrawn Phase Trials for Vorinostat (DB02546)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01695057Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast CancerTreatment